Job Description:1. To achieve the maximum profit of YungShin Group (YSG) by supervising joint ventures and integrating resources2. To increase the profit margins of YSG and develop the business of joint ventures by planning and implementing acquisitions or new complementary investment projects3. Supervise and manage the administration of joint ventures4. Plan acquisitions or new complementary investment projects for YungShin Global Holding Corporation (YSH)5. Developed and spearheaded the business plan6. Take charge of assignments from the chairman and board of directorsAccomplishments:- Restructured subsidiaries for efficiency both in operations and profitability- Optimized business plans to maximize profit margins by consolidating resources among the subsidiaries (EPS was increased by 36% in 2018 vs 2017)

- Developed the international RX marketing strategies, especially in the US- Selected ANDA pipeline for product development and planned the marketing platform to sell generic drugs directly to national drug store chains, wholesalers, and GPO (hospitals)

- In charge of all daily operation activities including the Business Development, Production, Warehouse, QA, QC, Regulatory Affairs, and Technical Transfer departments- Developed the business model for the USA market.- Negotiated with potential investing group (NJ USA) to go into business partnership

- I was in charge of all daily operation activities of the International Business Subsidiary at the China facilities, as well as the USA and UK branches- Led the International Business Subsidiary (Subsidiary) with 3 times growth of sales amount (UK OEM business) and operation income is in positive financial position during tenure as CEO- Established a good relationship with the UK client which has over 50 products' licenses, and I leveraged the client as a potential investment target to gain a better marketing position in Europe- Led the Subsidiary to increase the production output by 4 times since 2014- Led the Subsidiary's technical team to successfully pass UK-MHRA and USFDA onsite inspections at China facilities- Managed Subsidiary's two facilities to manufacture and develop oral solid chemical finished dosage for export to the OEM generic pharmaceutical markets: UK, Canada, New Zealand, and Germany- Developed China's Contract Manufacturing Organization for new drug development for clients whose submission target markets are China and USA- Set up USA branch in April 2013 in Nevada, contracted of outsourcing warehouse service in Ohio in May 2014, and applied for wholesaler permits in the 50 states of the USA to prepare for the Rx (ANDA) direct marketing and sales starting in the year of 2016- Proposed a business plan for the USA market whose key factors are: estimation of 7 years sales projection by selecting the Rx (ANDA) pipeline using IMS Data (USA market), supply chain management of choosing API sources and R&D partners, recommendation of set up in the USA branch in Nevada to consider the "No" state income tax benefit, and recommendation to choose outsourcing warehouse services in terms of saving initial startup cost- As a result, raised 800 million RMB (115 million USD) out of 1.3 billion RMB (186 million USD) approved by China SEC in October 2016 by my recommended USA and UK business model as mentioned above

- As the primary leader of the UK sales effort, I grew the European market revenue by 30 times in 1 year- Selected ANDA pipeline for product development in the US within 1 month of joining the company- Setup a subsidiary in Nevada to manage the US marketing platform to sell generic drugs directly to national drug store chains, wholesalers, and GPO (hospitals) within 6 months of joining the company

- Proposed a business plan of Rx (ANDA) for USA market and set up a USA branch in California, USA- Completed 2nd round of private investment

- In charge of the daily operation of all departments (Business Development, Production, Warehouse, QA, QC, Regulatory Affairs, Administration, and Technical Transfer)- Oversaw supply chain management- Grew the company sales amount by 3 times and positive operation income by 2 times- Established direct marketing channel to sell Rx drugs directly to customers (national chain drug stores, hospitals, and national wholesalers)- Increased company's production output by 3 times- Coordinated the company's technical team to successfully pass FDA onsite inspections every year

- In charge of the daily operation of Accounting activities- Involved in executive decisions for company growth with business models and marketing strategies

- Supervised the daily operations of accounting and HR activities

- In charge of all accounting operation activities and supervised accounting staff

- In charge of all accounting operation activities and supervised accounting staff

- Verified and certified financial records of companies by auditing various sources to ensure accounting records to present accurate views of financial situations- Discussed with client’s senior management regarding its financial condition- Examine and evaluate accounting, financial and internal control systems of clients to ensure that they are operating efficiently, effectively, and following GAAP- Led an auditing team to perform field job of auditing